BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/30/2025 9:08:50 AM | Browse: 12 | Download: 0
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Value of intravoxel incoherent motion and diffusion kurtosis imaging to differentiate hepatocellular carcinoma and intrahepatic cholangiocarcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shan-Mei Li, Meng-Wei Feng, Guang-Hai Ji, Xiao-Peng Song, Wei Mao, Tao Zhou, Xiao-Fang Guo, Zi-Long Yuan and Yu-Lin Liu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chutian Talents of Hubei |
No. CTYC001 |
| Talent Project of Hubei Cancer Hospital |
No. 2025HBCHLHRC001 |
| Clinical Medical Science and Technology of Jinan |
No. 202134053 |
|
| Corresponding Author |
Zi-Long Yuan, Associate Professor, Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 116 Zhuodaoquan South Road, Hongshan District, Wuhan 430079, Hubei Province, China. yuanzilong0213@126.com |
| Key Words |
Hepatocellular carcinoma; Magnetic resonance imaging; Intrahepatic cholangiocarcinoma; Intravoxel incoherent motion; Diffusion kurtosis imaging |
| Core Tip |
This study employed intravoxel incoherent motion (IVIM) and diffusion kurtosis imaging (DKI) for liver cancer and intrahepatic cholangiocarcinoma. The findings suggest that the parameters shifted apparent diffusion coefficient (SADC) and pure diffusion coefficient from IVIM and mean kurtosis coefficient and mean diffusion coefficient from DKI, can differentiate between the two tumor types. Among them SADC demonstrated the highest diagnostic value, and particularly when used in the joint model. The innovation of this lies in the application of the DKI sequence for the first time and analyze its value. |
| Citation |
Li SM, Feng MW, Ji GH, Song XP, Mao W, Zhou T, Guo XF, Yuan ZL, Liu YL. Value of intravoxel incoherent motion and diffusion kurtosis imaging to differentiate hepatocellular carcinoma and intrahepatic cholangiocarcinoma. World J Gastrointest Oncol 2025; In press |
 |
Received |
|
2025-04-21 05:26 |
|
Peer-Review Started |
|
2025-04-21 05:27 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-05-22 10:09 |
|
Revised |
|
2025-05-27 07:32 |
|
Second Decision |
|
2025-06-30 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-06-30 09:08 |
|
Articles in Press |
|
2025-06-30 09:08 |
|
Publication Fee Transferred |
|
2025-05-28 14:28 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
